Introduction
Angiogenesis is the generation of new blood vessels from the existing vascular network, and takes place during development, wound healing, and significantly, is recognized to be an indispensable component of solid tumor growth (Folkman, 1971 (Folkman, , 2000 Folkman and Hanahan, 1991; Carmeliet and Jain, 2000) . As the diffusion limit of oxygen is around 200 mm in solid tissue, any tumor greater than 1-2 mm in diameter must have a dedicated blood supply to grow and remain viable (Semenza, 1998; Carmeliet and Jain, 2000; Harris, 2002) . As a result of the central role played by angiogenesis in tumor progression, much effort has been expended to understand the mechanisms involved in nascent blood vessel growth, survival and maintenance with the goal that the information obtained from these studies will lead to potential new drugs and therapies to inhibit angiogenesis and therefore new tumor growth. However, the mechanisms underlying and contributing to angiogenesis are incompletely understood. Therefore, examination of the factors that facilitate angiogenesis, and their modulation, will provide a better mechanistic understanding of this process and may indicate additional ways to control angiogenesis.
Several members of the Ets family of transcription factors have been shown to contribute to angiogenesis (Lelievre et al., 2001; Sato, 2001) . The Ets family of transcription factors contain a unique DNA-binding domain (the Ets domain), recognizing and binding to a core GGAA/T consensus sequence in the promoters or enhancers of their target genes (Sementchenko and Watson, 2000; Oikawa and Yamada, 2003; Hsu et al., 2004) .
ETS1 was shown to be the first transcription factor expressed in endothelial cells undergoing angiogenesis (Vandenbunder et al., 1989; Wernert et al., 1992) . It has been subsequently demonstrated that ETS1 expression is induced by a wide spectrum of bioactive molecules including nitric oxide (Shimizu et al., 2004) , H 2 O 2 (Yasuda et al., 1999) , angiogenic growth factors such as vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) (Iwasaka et al., 1996) , tumor necrosis factor-a (TNF-a) (Goetze et al., 2001 ) and HGF (Tomita et al., 2003) , as well as hypoxia Watanabe et al., 2004) . Consistent with its induction by angiogenic factors, much evidence has been gathered demonstrating the functional role of ETS1 in the facilitation and progression of angiogenesis. Specifically, it has been shown that antisense oligonucleotides directed against ETS1 mRNA dramatically reduce the expression of ETS1 protein and results in a strong inhibition of migration, invasion and in vivo angiogenesis (Iwasaka et al., 1996; Chen et al., 1997; Wernert et al., 1999) . Dominant-negative ETS1 inhibits motility of cancer cells (Delannoy-Courdent et al., 1998; Kita et al., 2001) and in vivo angiogenesis (Nakano et al., 2000; Pourtier-Manzanedo et al., 2003) . Despite these phenotypic observations, the modulation of ETS1 protein interactions and functional activity remain incompletely defined in the setting of angiogenesis.
Interferons (IFNs) are known to possess antiangiogenic properties and are now used as a therapy in the treatment of benign infantile hemangiomas (Hastings et al., 1997; Tryfonas et al., 1998) and cancer (Kumar et al., 2002; Marler et al., 2002) . Although progress has been made in understanding the antiangiogenic effect of IFNs (von Marschall et al., 2003; Wang et al., 2003) , the mechanisms of this IFN action remain incompletely understood. SP100, a constituent member of the nuclear body (also called PML body), is one of the proteins whose expression is potently induced by IFN (Guldner et al., 1992; Yordy et al., 2004) , but the functional role of SP100 in endothelial cells has not been examined.
We have previously shown that SP100 interacts with ETS1, reduces ETS1-DNA binding, decreases the transcriptional activity of ETS1 and inhibits MDA-MB-231 invasion (Yordy et al., 2004) . However, no work to date has examined the biology of SP100, or the functional interaction between SP100 and ETS1, in endothelial cells. We therefore performed both functional and microarray studies and demonstrate that SP100 inhibits ETS1 biological activity in endothelial cells.
Results

SP100 and ETS1 expression is induced in primary endothelial cells
To characterize the expression and modulation of endogenous ETS1 and SP100 protein abundance in primary endothelial cells, the levels of ETS1 and SP100 protein were assessed following the addition of various agents known to alter the expression of these proteins in other cellular contexts. Consistent with previous observations demonstrating retinoic acid (RA)-and IFNmediated upregulation of SP100 protein expression in other cell types (Guldner et al., 1992; Pelicano et al., 1997; Yordy et al., 2004) , these agents increased the expression of SP100 in endothelial cells (Figure 1a) . RA has been shown to both decrease and increase ETS1 protein expression (Raouf et al., 2000; Igarashi et al., 2001) , and we observed an increase in ETS1 expression following RA treatment in endothelial cells (Figure 1a) .
It is well documented that the expression level of ETS1 protein in endothelial cells is increased following the addition of growth factors and cytokines that positively contribute to angiogenesis, such as VEGF (Iwasaka et al., 1996; Watanabe et al., 2004) and TNF-a (Goetze et al., 2001) . However, the potential modulation of SP100 protein in response to these factors has not been examined. Possible effects on DAXX, which is also a component of the nuclear body, interacts with ETS1 and inhibits ETS1 transcriptional activity , have also not been determined. Therefore, the expression of SP100, ETS1 and DAXX was evaluated following administration of TNF-a and lipopolysaccharide (LPS). Interestingly, TNF-a, a cytokine that is often expressed during tumor angiogenesis, and to a lesser extent LPS, an inflammatory molecule that induces the expression of cytokines and stress response genes, increased the expression of SP100 (Figure 1b ). TNF-a induced the expression of ETS1 in endothelial cells, and we also observed an increase in DAXX protein The expression of SP100, Daxx and ETS1 protein was examined by Western analysis following treatment with 1000 U/ml IFN-a, 1000 U/ml IFN-g, 5nM TNF-a or 1 mg/ml LPS as indicated. bActin was used as a loading control. (c) The expression of ETS1, SP100 and DAXX protein was examined by Western analysis following treatment with 20 ng/ml VEGF for 6, 12 and 24 h as indicated. b-Actin was used as a loading control. (d) The expression of ETS1, SP100 and DAXX protein was examined by Western analysis following treatment with 100 mM CoCl 2 for the indicated times. b-Actin was used as a loading control SP100 modulates migration and invasion JS Yordy et al expression following TNF-a treatment (Figure 1b) . VEGF increased the level of ETS1 protein over time, but did not significantly affect SP100 or DAXX expression (Figure 1c ). ETS1 protein has been shown to increase in response to hypoxic conditions Watanabe et al., 2004) , so the modulation of SP100 protein expression using the hypoxia mimetic CoCl 2 was also tested. While ETS1 protein levels increased in response to CoCl 2 , no significant increase in SP100 or DAXX protein expression was observed (Figure 1d ).
Magnitude and kinetics of protein expression is affected by adenoviral multiplicity of infection (MOI) in primary endothelial cells
As an approach to examine the functional significance of the interaction between ETS1 and SP100 in primary endothelial cells, we used adenoviral vectors to deliver and modulate exogenous protein expression, since standard transfection techniques afforded inadequate transfection efficiency (data not shown). An adenoviral MOI of 100 was found to result in an infection of greater than 99% of the endothelial cells (data not shown) and Western blot analysis demonstrated that ETS1 and SP100 protein expression increased throughout the course of the experiment (Figure 2 ). Based on the infectivity and kinetics of protein expression, we chose to use 100 MOI and 16 h infection for functional analyses, and 12 h infection followed by 12 h treatment with or without VEGF as per the experimental conditions used in each of the microarray experiments.
SP100 modulates ETS1-dependent endothelial cell morphology in Matrigel network assays
The functional consequences of the SP100 and ETS1 interaction were examined using the human umbilical In accordance with its known proangiogenic properties (Lelievre et al., 2001; Sato, 2001) , ETS1 expression consistently resulted in altered cellular morphology, indicated by a broadening and thickening of the cell network structure (Figure 3a1 versus a4 ). This phenotypic change required elevated ETS1 expression prior to In all migration and invasion experiments, cells were plated in serum-free medium, and EGM2 medium containing 10% FBS was placed in the bottom of the migration or invasion chamber. Migration was allowed to proceed for 8 h and invasion for 24 h. (e) Viable cell number was monitored using the MTT assay. Readings were taken 24 h prior to plating for the invasion assay, at the time of plating and 24 h after plating, which corresponded to the end of the invasion experiment. For the migration and invasion assays, each point was performed in triplicate and the results are representative of two independent experiments. For the viability assay, each point was averaged from 16 replicates. Western blot analysis of SP100, ETS1, DN-ETS and b-actin expression from concurrently infected cells as in (c) and (d) is indicated using equivalent amounts of protein. ETS1 and DN-ETS were visualized on the same gel using the C20 ETS1 antibody Figure 5 Microarray analysis of differential gene expression resulting from the activity of ETS1, DN-ETS and SP100. (a) Unsupervised hierarchical clustering of all genes with an absolute log 2 value of 0.8 in at least one of the experimental groups indicated on the top of the cluster and for which an expression was called in each experiment. In each experiment, the control GFP adenovirus-infected cells were treated with VEGF except for the control cells that were compared to the cells infected with ETS1 adenovirus and not treated with VEGF, so that the control treatments were identical to the above-indicated respective conditions. (b) SOTA examination of the differentially expressed genes in (a). In all, 42 centroid vectors were used to identify and select a specific subset of genes that displayed similar expression within the ETS1 experiments and the DN-ETS and SP100 experiments, and reciprocal expression between these two groups SP100 modulates migration and invasion JS Yordy et al plating, as cells that were infected at the time of plating (Figure 3a5 -a8) or cells that were infected 8 h after plating (Figure 3a9 -a12) did not show any differences in morphology between any of the treatment groups. Interestingly, consistent with a previous report stating that a dominant-negative ETS1 increased cell adhesion and spreading (Mattot et al., 2000) , network formation by DN-ETS-infected cells was faster; however, the stability of the network was decreased (Figure 3a3 versus a4). No cellular network formation was observed when the cells were plated on two-dimensional (2D) collagen Type I, indicating that the morphological response was specific to Matrigel (Figure 3b ). To test directly the significance of the functional interaction between ETS1 and SP100, network formation of HUVECs coinfected with adenoviruses expressing p51-ETS1 and SP100 were compared to cells infected with a single treatment of adenovirus expressing green fluorescent protein (GFP) control, p51-ETS1, p42-ETS1 (an ETS1 isoform encoded by an alternatively spliced mRNA lacking Exon VII), DN-ETS and SP100. Expression of either p51-ETS1 or p42-ETS1 alone resulted in a broadening and thickening of the network structures compared to GFP-infected cells (Figure 3c2 and c3 compared to c1). Coexpression of SP100 with p51-ETS1 reduced the thickness of the network, resulting in morphology very similar to cells infected with the SP100 adenovirus or the GFP control virus (Figure 3c6 compared to c5 and c1).
SP100 inhibits the migration and invasion of primary endothelial cells
To further assess the biological effects of SP100 protein expression and the functional interaction between ETS1 and SP100 in primary endothelial cells, migration and invasion assays were conducted. HUVECs were infected with the control adenovirus expressing GFP, or adenovirus expressing p51-ETS1, p42-ETS1, antisense ETS1, DN-ETS, or SP100 (Figure 4a and b) . Expression of SP100 reduced both migration and invasion compared to the GFP-expressing control cells. Significantly, in concordance with the promigratory effects of ETS1 (Lelievre et al., 2001; Sato, 2001) , expression of p51-ETS1 increased migration and invasion. We also observed an increase in migration and invasion by cells expressing p42-ETS1. Although the expression levels for p51-ETS1 and p42-ETS1 are similar (data not shown), the resultant enhancement of migration and invasion observed following p42-ETS1 expression was less than that observed for p51-ETS1, indicating that p42-ETS1 activity partially mimics p51-ETS1 activity in this context. In contrast, cells expressing antisense ETS1 and DN-ETS displayed a reduction in migration and invasion.
To test directly the effect of SP100 expression on the migration-and invasion-enhancing activity of ETS1, HUVECs were coinfected with ETS1 plus the control GFP virus or ETS1 plus SP100. In both the migration and invasion experiments, coexpression of SP100 with ETS1 reduced the migration and invasion of these cells by more than 50% relative to the migration and invasion of cells coinfected with ETS1 and control GFP (Figure 4c and d). Representative Western blot analysis was carried out to monitor protein expression during these experiments ( Figure 4d ). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell viability assays were also conducted and showed minimal effect of the virus treatment over the time course of the experiment (Figure 4e ).
Examination of the reprogramming of gene expression by ETS1, dominant-negative Ets and SP100
ETS1 biological effects, which are modulated by SP100, are mediated through the expression of specific target genes and we have previously shown that SP100 reduces ETS1 transcriptional activity on two ETS1-responsive promoters and inhibits ETS1-DNA binding. Therefore, cDNA microarrays were used to test the hypothesis that SP100 generally alters the expression of ETS1-responsive genes, leading to a global reprogramming of gene expression. Gene expression in cells infected with ETS1 adenovirus (ETS1), ETS1 adenovirus with VEGF in the medium (ETS1 þ V), SP100 adenovirus with VEGF in the medium (SP100 þ V) or DN-ETS adenovirus with VEGF in the medium (DN þ V) was compared to cells infected with control GFP-expressing adenovirus with or without VEGF in the medium as per the experimental condition (see Supplemental Table I for the complete expression data set). An expression data set excluding any gene that was not represented in all of the experiments was created and further filtered to include only those genes which were differentially expressed, defined as an absolute log 2 value of at least 0.8, in at least one of the experiments. This final data set Figure 6 Functional analysis of the differentially regulated genes from the microarray experiments. (a) Homogeneity analysis of the relatedness in the functional over-representation of differentially expressed genes from the four microarray experiments. The four microarray experiments are indicated, and the differentially expressed genes were divided into up-and downregulated categories. Downregulated groups are indicated with a red circle (ETS1 and ETS1 þ VEGF) or a red square (SP100 þ VEGF and DN þ VEGF) and upregulated genes are indicated with a green circle (ETS1 and ETS1 þ VEGF) or a green square (SP100 þ VEGF and DN þ VEGF). This analysis was conducted using the program Gifi. (b and c) GenMAPP graphical representation of several of the highly ranked over-represented GO classification categories identified following increased SP100 expression (b) and the effect of increased ETS1 expression on these categories (c). All differentially expressed genes for each experiment, both up-and downregulated, were used to assess over-representation. (d) LocusLink (LL) identifier-based literature profiling on 70 of the genes from the SOTA filtering. For each gene, collections of abstracts whose titles contained the official gene name, symbol or alias were extracted from Medline. Term occurrences were computed using WordStat 4.0 and keywords or categories sharing similar occurrence frequencies were grouped using two-way unsupervised hierarchical clustering. The most prominent cluster to emerge from this analysis was a subset of proteins belonging to the heat-shock family of genes. A detail from the heatmap highlighting this cluster is shown represented over 1000 features, where the downregulated genes are represented in blue and the upregulated genes are represented in yellow for enhanced contrast.
After hierarchical clustering, the two ETS1 experiments showed a high degree of overlap ( Figure 5a ). Interestingly, while the degree of overlap between the DN and SP100 modulates migration and invasion JS Yordy et al SP100 experiments was not as high as for the two ETS1 experiments, these two experiments clustered together (Figure 5a ), which is consistent with the model that both DN-ETS and SP100 negatively modulate ETS1 activity.
To further reduce the complexity of the differentially regulated genes, a self-organizing tree algorithm (SOTA) was used to create 42 similarly expressed clusters surrounding a centroid vector. As our hypothesis was that SP100 directly inhibits ETS1 activity, this enabled the selection of gene clusters that represented reciprocal regulation between the grouped ETS1 experiments and a group consisting of the DN-ETS and SP100 experiments, resulting in 129 features (representing 115 Unigene clusters and several additional IMAGE clones), depicted using the traditional color scheme of upregulated genes in red and downregulated genes in green (Figure5b and Supplemental Table II ). Since we selected for genes that showed reciprocal regulation, the degree of similarity was very high between the two ETS1 experiments and the DN-ETS and SP100 experiments. However, we unexpectedly discovered that the majority of genes showing reciprocal expression between these two groups were upregulated in the DN-ETS and SP100 experiments and downregulated in the two ETS1 experiments.
Phenotypic and functional in silico analysis of differentially regulated genes
To determine the similarities in the functional overrepresentation of the differentially expressed genes, classification based on homogeneity analysis was performed with the gene ontology (GO) classification using the program Gifi (Cui et al., 2004) . As expected, based on the clustering of differentially expressed genes (Figure 5a ), the degree of relatedness in the functional over-representation of the up-and downregulated genes in the two ETS1 experiments was very high (Figure 6a ). While the similarity in the functional representation for the upregulated genes in the DN and SP100 experiments was also very high, there was less similarity between DN-ETS and SP100 downregulated genes (Figure 6a ).
To further examine and extend the global functional relatedness of the GO classifications (Figure 6a ), the over-represented categories in all three GO classifications were statistically ranked using the GenMAPP and MAPPFinder programs (Dahlquist et al., 2002; Doniger et al., 2003) . We examined the ontology rankings for both up-and downregulated genes from each experiment separately or combined into one group of differentially regulated genes. For the ontology rankings depicted in Figure 6b and c, all differentially expressed genes from each experiment (combined up-and downregulated genes) were used to assess over-representation. Chaperone activity and heat-shock protein (HSP) activity were among the highest over-represented GO groups for the SP100 microarray experiment, and were downregulated in the two ETS1 experiments. Negative regulation of angiogenesis was also ranked very highly. An abbreviated listing of the top 20 GO classifications, along with selected terms that relate to motility, migration and angiogenesis are also listed along with their original rank (Table 1) . Only terms that exceeded a permuted P-value of less than 0.05 were included in this table.
In order to more completely examine the functional relatedness of the genes in the SOTA cluster, literature profiling (Chaussabel and Sher, 2002; Chaussabel et al., 2003; Edwards et al., 2003) was carried out on 70 genes from the SOTA filter. Abstracts for each of the selected genes were extracted from Medline, keyword frequencies for all abstracts for each of the genes were obtained and analyzed, and unsupervised hierarchical clustering was carried out using the term frequencies and the genes. Interestingly, the most prominent cluster to emerge from this analysis was a subset of proteins belonging to the heat-shock family of genes (Figure 6d) , which is consistent with the findings from the GO classification rankings.
Validation of differentially regulated genes and SP100 expression following heat shock Based on the previously described functional data, manual literature searches combined with the functional bioinformatics approaches listed above were used to select a subset of differentially regulated genes for validation using real-time PCR (Figure 7a ). The majority of the selected genes (12/16) were from SOTA filtering. Four genes chosen from the SOTA filter belong to the HSP family (H11, HSPA1L, HSPA8, HSPE1) and represent the single largest functional grouping in the GenMAPP and refined SOTA analyses. Based on this over-representation, HSPA6 was also chosen due to its overexpression in the SP100 experiment. The remaining eight of the genes from the SOTA filter (AXIN1, BRCA1, GABRE (gamma-aminobutyric acid A (GABA) receptor epsilon), ICAM1, PPP2R1B, RASSF2, SNAI1, SRD5A1 (steroid-5-alpha-reductase 1)) have been directly or indirectly implicated in motility, migration, invasion or angiogenesis, as determined by a more extensive examination of the complete texts of the gene-specific literature than provided by the bioinformatics approaches. In addition, CD14, CTGF (connective tissue growth factor) and THY1 were chosen because they displayed a high degree of differential regulation by ETS1 and are implicated in the modulation of motility or display differential expression during angiogenesis. Real-time PCR analyses of these genes demonstrated differential expression consistent with the microarray data, thus providing a high degree of validation for the microarray results.
The finding that HSP and SP100 expression were correlated prompted us to test whether SP100 was induced by heat shock. Two forms of heat shock were tested, continuous exposure to 401C heat shock and 1 h exposure to 431C heat shock, followed by recovery at 371C (Figure 7b ). Increased expression of SP100 protein was not detected in either the control time course or in the continuous 401C heat shock (Figure 7b , left and middle panel, respectively). However, exposure of the HUVECs to classical heat shock at 431C resulted in the (Figure 7b , right panel, compare 0 and 2 h time points), suggesting that SP100 expression is responsive to heat shock.
Discussion
In previous work, we demonstrated that SP100 interacts with ETS1, represses ETS1 DNA binding and transcriptional activity and inhibits ETS1-mediated invasion of MDA-MB-231 cells (Yordy et al., 2004) . While both ETS1 and SP100 are expressed in endothelial cells, the specific biological consequences of the functional interaction between SP100 and ETS1 in endothelial cells have not been examined. In this work, both functional and microarray analyses were undertaken to test the hypothesis that the functional interaction between ETS1
and SP100 leads to the inhibition of ETS1 proangiogenic activity.
SP100 and ETS1 expression levels are modulated by bioactive molecules
Both SP100 and ETS1 are expressed in primary HUVECs. This is the first demonstration that SP100 expression is strongly induced by IFN-a, IFN-g, TNF-a and to a lesser extent LPS (Figure 1 ), as well as by heat shock (Figure 7b ), in endothelial cells. In concordance with the published data, ETS1 expression is induced by the angiogenic growth factor VEGF and the inflammatory and angiogenic cytokine TNF-a, as well as hypoxic stress, but not by IFN-a or IFN-g in endothelial cells (Figure 1) . Thus, both ETS1 and SP100 expression is 
SP100 is a negative modulator of ETS1-mediated biological processes
The expression of ETS1, in agreement with its known proangiogenic and promigratory properties (Lelievre et al., 2001; Sato, 2001; Dittmer, 2003) , affected HUVEC network morphology (Figure 3 ) and increased HUVEC in vitro migration and invasion (Figure 4) . Significantly, SP100 repressed these ETS1-mediated morphological changes (Figure 3 ) and also reduced ETS1-mediated migration and invasion (Figure 4) , thus indicating that SP100 inhibits the biological activity of ETS1 in endothelial cells.
Functional genomics analysis of the reprogramming of gene expression by SP100 and ETS1
As a transcription factor, ETS1 modulates gene expression, resulting in changes in biological properties in endothelial cells that promote angiogenesis. We utilized microarray analyses to test the hypothesis that increased expression of SP100 modulates the reprogramming of ETS1-responsive gene expression. We also used dominant-negative ETS to further identify ETS-responsive genes, a portion of which are ETS1-responsive. While exogenous overexpression of ETS1 and SP100 may modulate genes regulated by other Ets family members, the differentially expressed genes identified may define novel Ets-regulated pathways in angiogenesis.
The complexity of the data set of differentially regulated genes (Figure 5a ) was further reduced using SOTA to identify a subset of 129 features that were reciprocally regulated between ETS1 and both DN and SP100 (Figure 5b ). We validated differential expression of genes (Figure 7a ) selected through a combination of bioinformatics analyses (Figure 6 ) to identify overrepresented functional groups and comprehensive literature searches to identify genes that potentially modulate motility. Group 1 (HSPs), the largest overrepresented functional group in the SOTA analysis, Group 2 (genes potentially involved in the modulation of motility, migration, invasion or angiogenesis) and Group 3 (genes that showed strong differential regulation by ETS1 and were also directly or indirectly implicated in motility) are briefly discussed below. Interestingly, SP100 did not modulate the expression of Group 3, indicating selectivity in the genes coregulated between ETS1 and SP100.
Differential gene regulation by SP100 and ETS1 Group 1 HSPs: Heat shock and hyperthermia have been shown to be antiangiogenic (Roca et al., 2003) and HSPs are also capable of directly modulating the stability of transcriptional regulatory complexes (Freeman and Yamamoto, 2002).
Group 2 AXIN1:
The Wnt/b-catenin pathway has been shown to enhance HUVEC migration (Hanai et al., 2002) . Axin1, a critical negative regulator of the Wnt/ b-catenin pathway, modulates the levels and activity of b-catenin (Kishida et al., 1999 (Kishida et al., , 1998 and may be the limiting component in the Wnt/b-catenin pathway (Lee et al., 2003; Tolwinski and Wieschaus, 2004) .
BRCA1: BRCA1 directly interacts with the estrogen receptor a (ER-a) and antagonizes ER-a stimulation of VEGF expression (Kawai et al., 2002) . ETS2 negatively regulates BRCA1 through the formation of a repressor complex with SWI/SNF on a functional EBS in the BRCA1 promoter (Baker et al., 2003) .
GABRE: GABRE is a component of the multisubunit GABA A receptor (Davies et al., 1997) . Recent evidence shows that GABA and GABA receptor signaling may play an inhibitory role in cell motility and tumorigenesis (Ortega, 2003; Entschladen et al., 2004) .
ICAM1: The expression of ICAM1 is reduced in activated tumor endothelial cells relative to endothelial cells from nontumor tissue (Griffioen et al., 1996; Dirkx et al., 2003) . 17b-Estradiol inhibits the expression of ICAM1 in cultured endothelial cells (Galea et al., 2002) . While these findings support an antiangiogenic function for ICAM1, it has also been reported that ICAM1 promotes in vitro endothelial cell motility (Kevil et al., 2004) . A functional EBS is present in the ICAM1 promoter (Roy et al., 2001) .
SNAI1: SNAI1 (Snail), a regulator of epithelial-tomesenchymal transition (Thiery, 2002) , has recently been shown to inhibit progression through the cell cycle (Vega et al., 2004) . In addition, Snail represses the expression of aromatase, which is responsible for converting androgen to estrogen (Okubo et al., 2001) .
SRD5A1: SRD5A1 and SRD5A2 convert testosterone into the more potent androgen dihydrotestosterone (DHT). SRD5A1, but not SRD5A2, expression was detected in HUVEC by RT-PCR (data not shown). The conversion of testosterone to either DHT or estrogen may negatively or positively modulate angiogenesis, respectively. 17b-Estradiol induces ETS1 expression and stimulates capillary sprouting, which was inhibited by pretreatment with antiestrogens or antisense ETS1 oligonucleotides (Lincoln et al., 2003) . In contrast, treatment of cancer cells with androgens reduced expression of MMP1, MMP3 and MMP7, and repressed ETS1, PEA3 and ERM activation of the MMP1 promoter (Schneikert et al., 1996) . Group 3 CD14: CD14, a LPS binding protein, is part of the LPS receptor complex and facilitates LPS signaling (Triantafilou and Triantafilou, 2002) . LPS enhances angiogenesis and tumor growth, invasion and metastasis (Li et al., 1991; Harmey et al., 2002; Pollet et al., 2003) .
CTGF: CTGF has been shown to have both pro-and antiangiogenic properties (Babic et al., 1999; Shimo et al., 1999; Brigstock, 2002; Hashimoto et al., 2002; Inoki et al., 2002; Chang et al., 2004; Jang et al., 2004) . CTGF mRNA is reduced in purified activated tumor SP100 modulates migration and invasion JS Yordy et al endothelial cells compared to purified endothelial cells from normal tissue (St Croix et al., 2000) and is strongly repressed in endothelial cells during capillary morphogenesis in 3D collagen matrices (Bell et al., 2001) . CTGF also inhibits Wnt signaling (Mercurio et al., 2004) . THY-1: Endothelial cell expression of THY-1 is increased during tumor angiogenesis (Lee et al., 1998) . Interestingly, THY-1 was found to be upregulated in endothelial cell tubule morphogenesis in three different models of in vitro angiogenesis (Gerritsen et al., 2002) and THY-1 expression is reduced in the absence of estrogen .
Conclusion
Several observations have emerged from the analysis of the functional studies in combination with the microarray data. First, we unexpectedly discovered that the majority of genes showing reciprocal expression between the two ETS1 experiments and the DN and SP100 experiments were upregulated by DN and SP100 and downregulated by ETS1. ETS1, in addition to activating gene expression, can repress the activity of several promoters (Dandre and Owens, 2004) , consistent with our observations that ETS1 both activates and represses gene expression. This supports the hypothesis that genes that are negatively regulated by ETS1 may play a central role in the proangiogenic functions of ETS1 and that the effects of the functional interaction between SP100 and ETS1 may result from the upregulation or derepression of ETS1-repressed genes. Second, SP100 modulates only a subset of genes responsive to ETS1 expression. This suggests that the activity of SP100 on ETS1 function may be geographically restricted within the nucleus. Third, ETS1 positively regulates the validated genes associated with enhanced migration or endothelial cell activation, while those that are negatively regulated by ETS1 and positively regulated by SP100 may contribute to the inhibition of migration, consistent with the biological responses mediated by ETS1 and SP100, respectively. Fourth, from the bioinformatics analysis of the functional genomics data from ETS1 and SP100 expression, it is clear that the activity of both proteins affects a wide range of biological processes.
Little work to date has been carried out to examine the functional role of many of the presented differentially regulated genes in endothelial cell biology and angiogenesis. Interestingly, some of these genes have overlapping themes (Wnt, estrogen and LPS signaling, etc.) and the brief findings listed above with regard to the biology of these genes warrant further study in endothelial cells and angiogenesis. In addition, further work will be required to determine if these genes are directly or indirectly regulated by ETS1 or other Ets proteins. The functional data presented here, and these expression data sets, serve as a starting point for further experimental work to identify these sentinel proteins and define their function in endothelial cells, thus also extending our understanding of ETS1 and SP100 biology.
Materials and methods
Cell culture and bioactive molecules
Primary HUVECs used in these studies were maintained at 371C under 5% CO 2 in EGM medium (Clonetics, Cambrex Corporation). IFN-a, IFN-g, TNF-a, RA and VEGF-121 were purchased from Calbiochem (EMD Biosciences Inc.). LPS and CoCl 2 were purchased from Sigma.
Western blots and antibodies
For Western analyses, cells were lysed in RIPA buffer containing protease inhibitors (Complete Protease Inhibitors, Roche). Equal amounts of total protein (20 mg) were resolved by 10% SDS-PAGE and subjected to Western blot analyses using SuperSignal West Pico (Pierce). Anti-SP100 rabbit polyclonal antibodies (98159 and 98160) were generated against amino acids 10-480 of SP100, prepared from GST-SP100-470 after thrombin cleavage. The anti-DAXX rabbit polyclonal antibody has been described previously . Polyclonal antibodies against ETS1 (C-20, sc-350) and b-Actin (C-11, sc-1615) were purchased from Santa Cruz Biotechnology. ETS1 monoclonal antibody (610362) was purchased from BD Transduction Laboratories/Becton Dickinson. b-actin monoclonal antibody (AC-15, ab6276) was purchased from Abcam. Secondary antibodies were purchased from Santa Cruz, Transduction Laboratories/Becton Dickinson and PharMingen/Becton Dickinson.
Recombinant adenoviral constructs
The pAdTrack-CMV adenoviral vectors were constructed and replication-deficient adenoviruses were made as described previously (He et al., 1998) . The pAdTrack-CMV vector was a gift from Dr Bert Vogelstein (The Johns Hopkins Oncology Center). pAdTrack-CMV contains bicistronic cytomegalovirus (CMV) promoters and expresses GFP under the control of one of the CMV promoters. Ad-GFP, which expresses only GFP, was used as control virus. All other adenoviruses expressed the gene of interest and GFP. Ad-p51-ETS1, Ad-DN-ETS, AdantisenseETS1 and Ad-SP100 have been described previously (Czuwara-Ladykowska et al., 2002; Yordy et al., 2004) . Adp42-ETS1 was constructed as follows. A 1.2 kb p42-ETS1 fragment was obtained from pUHD10-3-p42-ETS1 (Li et al., 1999) by an HpaI/KpnI double digestion and inserted into Kpn1/EcoRV sites of pAdTrack-CMV and the resulting shuttle vector (pAdTrack-CMV-p42-ETS1) was linearized with PmeI digestion and cotransformed with adenovirus backbone vector pAd-Easy-1 into recombination-competent Escherichia coli strain BJ5183. Recombinant adenovirus vectors containing p42-ETS1 coding sequence were identified by enzyme digestion, and expression was verified by Western blot. The recombinant viruses were prepared as high-titer stocks through propagation in 293 cells.
HUVEC network formation
HUVECs were infected at an MOI of 100 with the indicated adenoviruses 16 h prior to plating, at the time of plating and 8 h after plating on 2D Matrigel or collagen Type I. Network formation was examined using both 96-and 48-well plates. For the 96-well plates, 50 ml of ice-cold Matrigel or reconstituted collagen I were placed into each experimental well and allowed to solidify at 371C for 60 min. The Matrigel was thawed on ice overnight and used at full concentration. A 1 : 4 dilution of collagen I was prepared with three parts EGM medium, one part collagen I and 0.575% 1 N NaOH, mixed on ice. For the 48-well plates, 110 ml of Matrigel or reconstituted collagen I was placed into each experimental well and allowed to solidify at 371C for 60 min. A cell concentration of 5 Â 10 4 cells/cm 2 was found to be optimal for this assay, resulting in 1.6 Â 10 4 cells plated per well in the 96-well plates and 3.75 Â 10 4 cells plated per well in the 48-well plates. Bright field digital images were captured using either a Polaroid PDC-3000 digital camera or a Canon 10D digital camera using eyepiece projection through the camera port or afocal photography through the eyepiece cup, respectively, on an Olympus IX70 inverted microscope using adapters purchased from Adorama Camera Inc. (New York, NY, USA), Adirondack Video Astronomy (Glenn Falls, NY, USA) and ScopeTronix (Cape Coral, FL, USA).
Cell migration, invasion and proliferation assays
Cell migration experiments were carried out using 8-mm pore size migration chambers (Falcon, Becton Dickinson) precoated at 41C overnight with fibronectin (Becton Dickinson) at a concentration of 5 mg/cm 2 in PBS. The following day, the fibronectin solution was aspirated and the migration chambers were rinsed one time with water and allowed to air dry prior to the migration experiment. Cell invasion experiments were carried out using rehydrated 8-mm pore size invasion chambers precoated with Matrigel (Becton Dickinson). HUVEC cells (5 Â 10 4 ) in 500 ml of serum-free medium were added to each migration and invasion chamber. A measure of 750 ml EGM2 medium (Clonetics, Cambrex Corporation) containing 10% FBS was added to the underside of the chambers. Cells were allowed to migrate for 8 h or invade for 24 h at 371C in the presence of 5% CO 2 . Cells that did not migrate or invade were removed by wiping the top of the membrane with a cotton swab and the migrating and invading cells were fixed and stained with Diff-Quik as per the manufacturer's protocol (Dade Behring). Migrating and invading cells in 10 high-power fields in each chamber were counted. Cell viability was carried out using MTT according to the manufacturer's instructions (Sigma-Aldrich). Cells were assayed 24 h before the start of the migration and invasion experiments (8 h before infection with adenovirus), at the time of cell plating, and 24 h postplating, to coincide with the end of the invasion experiment.
Microarray protocol description and data analysis
Prior to hybridization, the cDNA microarray slides (Stanford, B43 000 elements printed on polyLysine-coated glass slides) were rehydrated, immobilized and blocked to deactivate the unused reactive surface of the slides. Briefly, a humid chamber was filled with 100 ml 1 Â SSC and the slides were placed printed side down in the humid chamber and allowed to rehydrate. After rehydration, the arrays were snap-dried on a 901C inverted heat block for 5 s, followed by UV crosslinking in a Stratalinker set for 65 mJ. After crosslinking, the slides were postprocessed to block any residual reactive groups on the slide prior to hybridization. The microarrays in a slide rack were plunged five times rapidly and evenly into the blocking solution (6 g succinic anhydride in 350 ml 1-methyl-2-pyrrolidinone to which was added 15 ml sodium borate) and subsequently blocked on an orbital shaker for an additional 20 min. After blocking was completed, the microarrays were placed into 951C water for 2 min, followed by plunging five times into 95% ethanol. The microarrays were centrifuged at 500 r.p.m. for 5 min at room temperature (Jouan) and used for hybridizations.
Total RNA was isolated using Trizol (Invitrogen) and was further purified by passing the RNA over an RNeasy mini column (Qiagen) following the provided protocol. Total RNA (16 mg) for both the control and experimental samples was used in the Superscript III Indirect cDNA Labeling System (Invitrogen) following the manufacturer's protocol. The purified cDNA with the incorporated amino-modified bases was covalently labeled with a succinimidyl ester Alexa Fluor dye, either Alexa Fluor 555 or Alexa Fluor 647 from the Alexa Fluor Reactive Dye decapacks (Molecular Probes) following the manufacturer's instructions. After labeling, the control and experimental cDNA probes were combined and column purified (Qiagen). In all, 20 mg COT-1 DNA, 10 mg tRNA and 10 mg polydA was added to the purified probes, which were then evaporated and resuspended to 35 ml in 3.4X SSC/0.3% SDS. After denaturation and reannealing, the labeled cDNA probe mixtures were applied to the cDNA microarrays, a coverslip was placed over the probe on the microarrays, which were then incubated in a hybridization cassette (ArrayIt) in a 651C water bath for 18 h. After hybridization, the coverslip was removed and the microarrays were washed for 5 min in 2X SSC/0.03% SDS, 5 min in 1X SSC and 5 min in 0.1X SSC, all at room temperature. Following the last wash, the microarray was spin-dried in a benchtop centrifuge (Jouan) and then scanned using a GenePix 4000b microarray scanner (Axon). Each experiment was carried out with dye swap.
Data were acquired and extracted using GenePix Pro 4.1 (Axon) and background correction, normalization and data visualization was carried out using TIGR TM4, including the programs MIDAS and MEV (Saeed et al., 2003) . The cutoff for acceptable feature extraction using MIDAS was a background checking signal-to-noise threshold of 1.5 (mean expression at least 1.5 times the median of the background in both channels). Block locfit normalization was performed for each slide with a smooth parameter of 0.33, followed by block standard deviation regularization to appropriately scale each print tip block. Flip dye consistency checking was used with the data trim option set to exclude any features with a flip dye variation greater than the slide cross log ratio of 72.0 s.d., and all flip dye features from the dye swap slides that passed this test were averaged. Slide standard deviation regularization to appropriately scale the expression data across all the experiments was carried out, resulting in the final normalized expression data set used for all downstream analyses. An expression data set excluding any feature that was not represented in all of the experiments was created, retaining features for which an expression was called (present) in each experiment and deleting features whose expression was not called (absent) in at least one experiment. Since the majority of the genes in this list were not differentially expressed, we further filtered the data to only include those genes that were differentially expressed in at least one of the experiments, defined by an absolute log 2 value of at least 0.8.
Further data filtering, unsupervised hierarchical clustering and SOTA were carried out using Genesis (Sturn et al., 2002) and MEV. Functional over-representation of the GO project (www.geneontology.org) gene classifications for the differentially expressed genes based on homogeneity analysis was performed using the program Gifi (Cui et al., 2004) . Functional analysis of the microarray data was conducted using the GO classifications with the program GenMAPP v2 beta (Dahlquist et al., 2002) , including the MAPPFinder program (Doniger et al., 2003) , with a cutoff for differential expression being an absolute log 2 fold change of 0.8 to statistically rank and rapidly view the over-represented GO classifications from all three gene ontologies: biological process ontology, cellular component ontology and molecular function ontology. The most current Unigene cluster IDs using the microarray feature GenBank ID were obtained from SOURCE (www.source.stanford.edu).
Literature profiling was carried out according to the established methods (Chaussabel and Sher, 2002; Chaussabel et al., 2003; Edwards et al., 2003) . Specifically, for each gene a collection of records for which the title contains official names, symbols or aliases were extracted from Medline. Term occurrences in abstracts were computed using a text processor (WordStat 4.0, Provalis Research) and keywords with high but specific occurrence levels were selected after removing terms with either high or low frequency across all genes to retain the few discerning terms characterized by a pattern of high occurrence for only a few genes. The term list was further reduced manually, and any similar words with similar meaning (i.e. cancer and cancers) were truncated to the root word with an asterisk (i.e. cancer and cancers becomes cancer*), which allows for the grouping of similar terms under one root heading (see Supplemental Table III for the vocabulary list). Keywords or categories sharing similar occurrence patterns were grouped using unsupervised hierarchical clustering. This approach has been used previously (Chaussabel and Sher, 2002; Chaussabel et al., 2003; Edwards et al., 2003) and has proven effective in finding functional similarities between genes of interest.
RNA isolation and real-time PCR
Total RNA was purified from HUVEC cells using Trizol (Invitrogen), and purified a second time using RNeasy minicolumns (Qiagen). cDNA was made from 2 mg of the purified total RNA using the SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen) according to the manufacture's protocol. A 1 : 10 or 1 : 5 dilution of the resulting cDNA was used for all real-time RT-PCR experiments. Real-time PCR was conducted using a LightCycler (Roche) with the Platinum SYBR Green qPCR SuperMix UDG (Invitrogen) according to the manufacturer's instructions. All primers were used at a concentration of 250 nM. The cycling conditions for all genes were: preincubation at 501C for 2 min, 951C for 2 min, followed by 30-50 cycles of denaturation at 941C for 5 s, annealing at 11C below the lowest Tm for a given primer pair for 5 s and extension at 721C for the indicated time in the primer table, with a single data acquisition at the end of each extension. All ramping was carried out at 201C/s. The cycling for S26 was identical to the above except the annealing was carried out at 551C and the extension was for 12 s. Melting curve analysis was conducted following the PCR cycling, using denaturation at 951C for 10 s, annealing at 581C for 15 s and stepping 0.11C/s from 58 to 951C with continuous data acquisition. Relative expression analysis was conducted using the program LinRegPCR according to the suggested specifications (Ramakers et al., 2003) . The primers used for real-time PCR are as given in Table 2 .
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